Bioneer approves change of manufacturing license for ‘COVID-19 and flu simultaneous diagnosis kit’
Bioneer announced on the 9th that it had recently applied for a manufacturing license change for the ‘AccuPower® RV1 Multiplex Kit’, a simultaneous diagnosis kit for COVID-19 and flu, from the Ministry of Food and Drug Safety to extend the validity period of the diagnostic reagent. This change application was a preemptive decision of Bioneer … Read more